发明授权
- 专利标题: VERFAHREN ZUR HERSTELLUNG VON STÄRKEESTERN FÜR KLINISCHE, INSBESONDERE PARENTERALE ANWENDUNG
- 专利标题(英): Method of preparing starch esters for clinical, in particular parenteral, applications
- 专利标题(中): 用于生产强度酯为临床特殊肠道应用
-
申请号: EP92914886.4申请日: 1992-07-09
-
公开(公告)号: EP0593605B1公开(公告)日: 1997-11-26
- 发明人: FÖRSTER, Harald , ASSKALI, Fatima , NITSCH, Ernst
- 申请人: Laevosan-Gesellschaft m.b.H.
- 申请人地址: Estermannstrasse 17 A-4020 Linz AT
- 专利权人: Laevosan-Gesellschaft m.b.H.
- 当前专利权人: Laevosan-Gesellschaft m.b.H.
- 当前专利权人地址: Estermannstrasse 17 A-4020 Linz AT
- 代理机构: Huber, Bernhard, Dipl.-Chem.
- 优先权: DE4123000 19910711
- 国际公布: WO9301217 19930121
- 主分类号: C08B35/02
- IPC分类号: C08B35/02 ; C08B31/04
摘要:
In order to prepare physiologically tolerated water-soluble starch esters, the invention proposes that starch is converted by acid hydrolysis or enzymatic hydrolysis to a partially hydrolysed form with a mean molecular weight in the range from 10,000 to 500,000 Daltons. This partial hydrolysate is then acylated, in aqueous solution, with the anhydride or halide of an aliphatic monocarboxylic acid with 2 to 4 carbon atoms or an aliphatic dicarboxylic acid with 3 to 6 carbon atoms, or mixtures thereof, and an alkalinization agent, to give a product with a substitution ratio in the range from 0.1 to 1.0 mole/mole. Salts are removed from the resulting reaction mixture. The starch esters thus obtained are highly suited for clinical use, in particular parenteral administration and administration in the diet.
信息查询